Herrmann Ken
SEC insider (Form 3/4/5 filer). CIK 0002049757. Director at Aktis Oncology, Inc. (AKTS). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 20, 2026. Located in BOSTON, MA.
Companies Herrmann Ken has filed insider reports for
- Aktis Oncology, Inc. (AKTS): Director
Herrmann Ken
CIK: 0002049757
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (50.0%)
Position reduction
Option Exercises (M)3 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKTS
Aktis Oncology, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 20, 2026AKTS
Aktis Oncology, Inc.
ExerciseDirect3.5K shares at avg. $0.08$280.48 - Jul 20, 2026AKTS
Aktis Oncology, Inc.
ExerciseDirect1.4K shares at avg. $1.91$3K - Jul 20, 2026AKTS
Aktis Oncology, Inc.
SaleDirect3.5K shares at avg. $24.56$86K - Jul 20, 2026AKTS
Aktis Oncology, Inc.
SaleDirect1.4K shares at avg. $24.56$33K - Jul 17, 2026AKTS
Aktis Oncology, Inc.
ExerciseDirect3.1K shares at avg. $0.08$245.2 - Jul 17, 2026AKTS
Aktis Oncology, Inc.
SaleDirect3.1K shares at avg. $25.21$77K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 20, 2026 | AKTS Aktis Oncology, Inc. | Exercise | 3,506 | $0.08 | $280 | Direct |
| Jul 20, 2026 | AKTS Aktis Oncology, Inc. | Exercise | 1,350 | $1.91 | $2,579 | Direct |
| Jul 20, 2026 | AKTS Aktis Oncology, Inc. | Sale | 3,506 | $24.56 | $86,115 | Direct |
| Jul 20, 2026 | AKTS Aktis Oncology, Inc. | Sale | 1,350 | $24.56 | $33,159 | Direct |
| Jul 17, 2026 | AKTS Aktis Oncology, Inc. | Exercise | 3,065 | $0.08 | $245 | Direct |
| Jul 17, 2026 | AKTS Aktis Oncology, Inc. | Sale | 3,065 | $25.21 | $77,259 | Direct |
1-6 of 6 transactions